Review Article| Volume 2, P101-112, September 2020

Bariatric Embolization

Is There a Role for Interventional Radiology in the Treatment of Obesity?
  • Jenanan P. Vairavamurthy
    Division of Vascular and Interventional Radiology, Department of Radiology, Keck School of Medicine of University of Southern California, 1500 San Pablo Street Suite 2, Los Angeles, CA 90033, USA
    Search for articles by this author
  • Omid Shafaat
    Division of Vascular and Interventional Radiology, Department of Radiology, Interventional Radiology Center, The Russell H. Morgan Department of Radiology and Radiological Science, The Johns Hopkins University School of Medicine, 1800 Orleans Street, Zayed Tower, Suite 7203, Baltimore, MD 21287, USA
    Search for articles by this author
  • Clifford R. Weiss
    Corresponding author.
    Division of Vascular and Interventional Radiology, Department of Radiology, Interventional Radiology Center, The Russell H. Morgan Department of Radiology and Radiological Science, The Johns Hopkins University School of Medicine, 1800 Orleans Street, Zayed Tower, Suite 7203, Baltimore, MD 21287, USA
    Search for articles by this author
      The current standard treatment options for obesity include lifestyle modifications, bariatric surgery, pharmacotherapy, endoscopic bariatric techniques, and a new interventional radiologic method called bariatric embolization.


      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Advances in Clinical Radiology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Afshin A.
        • Forouzanfar H.
        • Reitsma M.B.
        • et al.
        Health effects of overweight and obesity in 195 countries over 25 years.
        N Engl J Med. 2017; 377: 13-27
        • Adams K.
        • Schatzkin A.
        • Harris T.B.
        • et al.
        Overweight, obesity, and mortality in a large prospective cohort of persons 50 to 71 years old.
        N Engl J Med. 2006; 355: 763-778
        • Centers for Disease Control and Prevention
        Defining adult overweight and obesity.
        (Available at:) (Accessed March 29, 2017)
        • Ng M.
        • et al.
        Global, regional, and national prevalence of overweight and obesity in children and adults during 1980-2013: a systematic analysis for the Global Burden of Disease Study 2013.
        Lancet. 2014; 384: 766-781
        • Cheskin L.J.
        • Poddar K.
        Obesity management.
        in: Jordan W.H. Principles of human nutrition. HardPress Publishing, Miami (FL)2012: 788-801
        • United States Department of Health and Human Services
        National Institutes of Health, and National Heart Lung and Blood Institute, Managing overweight and obesity in adults. Systematic evidence review from the obesity expert panel.
        (Available at:) (Accessed March 22, 2017)
        • Wadden T.A.
        • Webb V.L.
        • Moran C.H.
        • et al.
        A lifestyle modification for obesity. New developments in diet, physical activity, and behavior therapy.
        Circulation. 2012; 125: 115-1170
        • World Health Organization
        Physical activity and adults.
        (Available at:) (Accessed March 29, 2017)
        • Carvajal R.
        • et al.
        Managing obesity in primary care practice: a narrative review.
        Ann N Y Acad Sci. 2013; 1281: 191-206
        • Blomian E.S.
        • Dirhan D.A.
        • Valentino M.A.
        • et al.
        Mechanisms of weight regain following weight loss.
        ISRN Obes. 2013; 2013: 210524
        • Stahl J.M.
        • Malhotra S.
        Obesity Surgery Indications And Contraindications.
        in: StatPearls. StatPearls Publishing, Treasure Island (FL)2020
        • Schauer P.R.
        • Bhatt D.L.
        • Kirwand J.P.
        • et al.
        Bariatric surgery versus intensive medical therapy for diabetes - 5 year outcomes.
        N Engl J Med. 2017; 376: 641-651
        • Singh D.
        • Laya A.
        • Clarkston W.
        • et al.
        Jejunoileal bypass: a surgery of the past and a review of its complications.
        World J Gastroenterol. 2009; 14: 2277-2279
        • Fobi M.
        Surgical treatment of obesity: a review.
        J Natl Med Assoc. 2004; 96: 61-75
        • Neylan C.J.
        • et al.
        The surgical management of obesity.
        Gastroenterol Clin North Am. 2016; 45: 689-703
        • Arterburn D.E.
        • Courcoulas A.P.
        Bariatric surgery for obesity and metabolic conditions in adults.
        BMJ. 2014; 349: g3961
        • Buchwald H.
        Gastric stimulation: a new paradigm for management of morbid obesity.
        Obes Surg. 2004; 14: S2
        • Bult M.J.
        • van Dalen T.
        • Muller A.F.
        Surgical treatment of obesity.
        Eur J Endocrinol. 2008; 158: 135-145
        • Fung M.
        • Wharton S.
        • Macpherson A.
        • et al.
        Receptivity to bariatric surgery in qualified patients.
        J Obes. 2016; 2016: 5372190
        • Weiner J.P.
        • Goodwin S.M.
        • Chang H.Y.
        • et al.
        Impact of bariatric surgery on health care costs of obese persons: a 6 year follow up of surgical and comparison cohorts using health plan data.
        JAMA Surg. 2013; 148: 555-562
        • Srivastava G.
        • Apovian C.M.
        Current pharmacotherapy for obesity.
        Nat Rev Endocrinol. 2018; 14: 12-24
        • Berthoud H.R.
        Interactions between the “cognitive” and “metabolic” brain in the control of food intake.
        Physiol Behav. 2007; 91: 486-498
        • Aronne L.J.
        • et al.
        Evaluation of phentermine and topiramate versus phentermine/topiramate extended release in obese adults.
        Obesity. 2013; 21: 2163-2171
        • Bray G.A.
        Medical treatment of obesity: the past, the present and the future.
        Best Pract Res Clin Gastroenterol. 2014; 28: 665-684
        • Torgerson J.S.
        • et al.
        XENical in the prevention of diabetes in obese subjects (XENDOS) study: a randomized study of orlistat as an adjunct to lifestyle changes for the prevention of type 2 diabetes in obese patients.
        Diabetes Care. 2004; 27: 155-161
        • Patel D.
        Pharmacotherapy for the management of obesity.
        Metabolism. 2015; 64: 1376-1385
        • Garvey W.T.
        • et al.
        Two-year sustained weight loss and metabolic benefits with controlled-release phentermine/topiramate in obese and overweight adults (SEQUEL): a randomized, placebo-controlled, phase 3 extension study.
        Am J Clin Nutr. 2012; 95: 297-308
        • Smith S.R.
        • et al.
        Multicenter, placebo-controlled trial of lorcaserin for weight management.
        N Engl J Med. 2010; 363: 245-256
        • O'Neil P.M.
        • et al.
        Randomized placebo-controlled clinical trial of lorcaserin for weight loss in type 2 diabetes mellitus: the BLOOM-DM study.
        Obesity (Silver Spring). 2012; 20: 1426-1436
        • Saunders K.H.
        • et al.
        Pharmacotherapy for obesity.
        Endocrinol Metab Clin North Am. 2016; 45: 521-538
        • Pi-Sunyer X.
        • et al.
        A randomized, controlled trial of 3.0 mg of liraglutide in weight management.
        N Engl J Med. 2015; 373: 11-22
        • Wadden T.A.
        • et al.
        Preface. Obesity and associated eating disorders: a guide for mental health professionals.
        Psychiatr Clin North Am. 2011; 34 (xiii–xvi)
        • Wadden T.A.
        • et al.
        Weight loss with naltrexone SR/bupropion SR combination therapy as an adjunct to behavior modification: the COR-BMOD trial.
        Obesity (Silver Spring, Md.). 2011; 19: 110-120
        • Bazerbachi F.
        • Vargas Valls E.J.
        • Abu Dayyeh B.
        Recent clinical results of endoscopic bariatric therapies as an obesity intervention.
        Clin Endosc. 2017; 50: 42-50
        • Neylan C.J.
        • et al.
        Endoscopic treatments of obesity: a comprehensive review.
        Surg Obes Relat Dis. 2016; 12: 1108-1115
        • ASGE Bariatric Endoscopy Task Force
        • ASGE Technology Committee
        • Abu Dayyeh B.K.
        • et al.
        Endoscopic bariatric therapies.
        Gastrointest Endosc. 2015; 81: 1073-1086
        • Kurian M.
        • Kroh M.
        • Chand B.
        • et al.
        SAGES review of endoscopic and minimally invasive bariatric interventions: a review of endoscopic and non-surgical bariatric interventions.
        Surg Endosc. 2018; 32: 4063-4067
        • Marinos G.
        • et al.
        Weight loss and improved quality of life with a nonsurgical endoscopic treatment for obesity: clinical results from a 3- and 6-month study.
        Surg Obes Relat Dis. 2014; 10: 929-934
        • Abu Dayyeh B.K.
        • Rajan E.
        • Gostout C.J.
        Endoscopic sleeve gastroplasty: a potential endoscopic alternative to surgical sleeve gastrectomy for treatment of obesity.
        Gastrointest Endosc. 2013; 78: 530-535
        • Kumar N.
        Endoscopic therapy for weight loss: gastroplasty, duodenal sleeves, intragastric balloons, and aspiration.
        World J Gastrointest Endosc. 2015; 7: 847-859
        • Sullivan S.
        • Swain J.M.
        • Woodman G.
        • et al.
        12 Month randomized sham controlled trial evaluating the safety and efficacy of targeted use of endoscopic suture anchors for primary obesity: The ESSENTIAL study.
        Gastroenterology. 2016; 150: S25-S26
        • Koehestanie P.
        • et al.
        The effect of the endoscopic duodenal-jejunal bypass liner on obesity and type 2 diabetes mellitus, a multicenter randomized controlled trial.
        Ann Surg. 2014; 260: 984-992
        • Stimac D.
        • Klobucar Majanovic S.
        • Licina M.
        Recent trends in endoscopic management of obesity.
        Surg Innov. 2016; 23: 525-537
        • Forssell H.
        • Noren E.
        A novel endoscopic weight loss therapy using gastric aspiration: results after 6 months.
        Endoscopy. 2015; 47: 68-71
        • Beckman L.M.
        • Beckman T.R.
        • Sibley S.D.
        • et al.
        Changes in gastrointestinal hormones and leptin after Roux-en-Y gastric bypass surgery.
        JPEN J Parenter Enteral Nutr. 2011; 35: 169-180
        • Weiss C.R.
        • et al.
        Clinical safety of bariatric arterial embolization: preliminary results of the BEAT obesity trial.
        Radiology. 2017; 283: 598-608
        • Sumithran P.
        • Prendergast L.A.
        • Delbridge E.
        • et al.
        Long-term persistence of hormonal adaptations to weight loss.
        N Engl J Med. 2011; 365: 1597-1604
        • Gunn A.J.
        • Oklu R.
        A preliminary observation of weight loss following left gastric artery embolization in humans.
        J Obes. 2014; 2014: 185349
        • Kojima M.
        • et al.
        Ghrelin is a growth-hormone-releasing acylated peptide from stomach.
        Nature. 1999; 402: 656-660
        • Wren A.M.
        • Bloom S.R.
        Gut hormones and appetite control.
        Gastroenterology. 2007; 132: 2116-2130
        • Arepally A.
        • et al.
        Catheter-directed gastric artery chemical embolization for modulation of systemic ghrelin levels in a porcine model: initial experience.
        Radiology. 2007; 244: 138-143
        • Arepally A.
        • et al.
        Catheter-directed gastric artery chemical embolization suppresses systemic ghrelin levels in porcine model.
        Radiology. 2008; 249: 127-133
        • Paxton B.E.
        • et al.
        Histopathologic and immunohistochemical sequelae of bariatric embolization in a porcine model.
        J Vasc Interv Radiol. 2014; 25: 455-461
        • Paxton B.E.
        • et al.
        Bariatric embolization for suppression of the hunger hormone ghrelin in a porcine model.
        Radiology. 2013; 266: 471-479
        • Diana M.
        • et al.
        Embolization of arterial gastric supply in obesity (EMBARGO): an endovascular approach in the management of morbid obesity. proof of the concept in the porcine model.
        Obes Surg. 2015; 25: 550-558
        • Weiss C.R.
        • Abioloa G.O.
        • Fischman A.M.
        • et al.
        Bariatric embolization of arteries for the treatment of obesity (BEAT obesity) trial: results at 1 year.
        Radiology. 2019; 291: 792-800
        • Pirlet C.
        • Ruzsa Z.
        • Costerousse O.
        • et al.
        Transradial left gastric artery embolization to treat severe obesity: a pilot study.
        Catheter Cardiovasc Interv. 2019; 93: 365-370
        • Elens S.
        • Roger T.
        • Elens M.
        • et al.
        Gastric embolization as treatment for overweight patients; efficacy and safety.
        Cardiovasc Intervent Radiol. 2019; 42: 513-519
        • Bai Z.B.
        • Qin Y.-L.
        • Deng G.
        • et al.
        Bariatric embolization of the left gastric arteries for the treatment of obesity: 9-month data in 5 patients.
        Obes Surg. 2018; 28: 907-915
        • Syed M.I.
        • Morar K.
        • Shaikh A.
        • et al.
        Gastric artery embolization trial for the lessening of appetite nonsurgically (GET LEAN): six-month preliminary data.
        J Vasc Interv Radiol. 2016; 27: 1502-1508
        • Kipshidze N.
        • Archvadze A.
        • Bertog S.
        • et al.
        Endovascular bariatrics: first in humans study of gastric artery embolization for weight loss.
        JACC Cardiovasc Interv. 2015; 8: 161-164
        • Hafezi-Nejad N.
        • et al.
        Weight loss after left gastric artery embolization: a systematic review and meta-analysis.
        J Vasc Interv Radiol. 2019; 30: 1593-1603.e3